newsfilter
← Latest News
FDA Approved Drugs·

Approval of Tafinlar, Nda #202806 (Labeling)

Approval Date: 03/26/2026; Drug Name: Tafinlar, Nda #202806; Active Ingredients: DABRAFENIB MESYLATE; Company: Novartis; Submission Status: Approval; Submission Classification: Labeling; Application Number: 202806

Company
NOVARTIS
Keywords
NOVARTIS